Sabiha Khan, MD, is a Scientific Reviewer at the U.S. Food and Drug Administration’s (FDA’s) Office of Therapeutic Biologics and Biosimilars (OTBB). She is a part of the interdisciplinary team which supports communicating clear, consistent scientific advice for biosimilar and interchangeable product development. Dr. Khan completed her rheumatology fellowship at the Johns Hopkins University, prior to which she completed her residency in internal medicine at Rush University Medical Center. She received her medical degree from the University of Virginia, and her Bachelor of Science in Biological Psychology from the College of William and Mary.

After completing her rheumatology fellowship, Dr. Khan established and grew her practice in general rheumatology with Johns Hopkins Community Physicians and also served as the Director of the Rapid Arthritis Care and Evaluation Clinic for the Division of Rheumatology at Johns Hopkins Hospital. Dr. Khan joined the Agency as a medical officer with the Division of Pulmonary, Allergy, and Rheumatology Products in 2020. Since then, she has worked in the Division of Rheumatology and Transplant Medicine (DRTM) and in OTBB.